antifungal resistance – Page 12

China’s innovative national plan to combat fungal diseases and antifungal resistance

mycolabadmin

China has created a comprehensive national system to fight fungal infections and drug resistance. The system monitors fungal diseases across hundreds of hospitals throughout the country to track which infections are most common and which antifungal medicines are becoming less effective. Early findings show that many hospitals lack proper facilities for testing fungal infections, and some fungi are developing resistance to commonly used antifungal drugs, particularly fluconazole.

Geotrichosis Due to Magnusiomyces capitatus: A Severe Emerging Invasive Fungal Disease

mycolabadmin

A 71-year-old man with cancer undergoing chemotherapy developed a rare and serious fungal blood infection caused by Magnusiomyces capitatus. Despite treatment with antifungal medications, the infection spread throughout his body and he died 10 days after admission. This case highlights how some fungi can resist common antifungal drugs and the importance of quickly identifying the exact type of fungus causing an infection to choose the right treatment.

Insights into Persian Gulf Beach Sand Mycobiomes: Promises and Challenges in Fungal Diversity

mycolabadmin

Researchers studied fungi found in sand and water at beaches along Iran’s Persian Gulf and Sea of Oman coastlines. They discovered high levels of potentially harmful fungi, particularly Aspergillus terreus, which can cause respiratory infections. The study found that while some antifungal drugs like voriconazole were effective, some fungi showed resistance to common treatments. This information is important for protecting swimmers and beach visitors from fungal health risks.

Targeted long-read sequencing analysis and antifungal susceptibility profiles of Sporothrix schenckii isolates from Thailand

mycolabadmin

This research examined a fungal infection called sporotrichosis found in Thailand, particularly in cats and humans. Scientists used advanced DNA sequencing technology to accurately identify which species of the fungus caused the infections and understand how they are related to each other. They also tested how well common antifungal medications work against these fungi, finding that some strains have become resistant to itraconazole, the main drug used to treat sporotrichosis.

Masquerading Yeast: A Case Report of Lomentospora prolificans Fungemia With a Diagnostic Twist

mycolabadmin

This case describes a patient with blood cancer who developed a rare and deadly mold infection called Lomentospora prolificans while receiving cancer treatment. The infection was difficult to diagnose initially because the fungal structures looked similar to yeast under the microscope, and a molecular test gave a false positive result for a different fungus. Unfortunately, the infection was resistant to all available antifungal medications and the patient died.

Azole fungicides and Aspergillus resistance, five EU agency report highlights the problem for the first time using a One Health approach

mycolabadmin

A major European health agency report warns that widely-used fungicides sprayed on crops to prevent plant diseases may be creating resistant fungi that can infect humans and make medical treatments ineffective. The study found that about 10,000 tonnes of these azole fungicides are used in Europe annually, and their residues accumulate in the environment where they can cause harmful fungi to become resistant to the same medicines doctors use to treat patients. The report calls for urgent action to better monitor this problem and prevent resistance through smarter use and regulation of agricultural fungicides.

Azole Resistance in Aspergillus Species Isolated from Clinical Samples: A Nine-Year Single-Center Study in Turkey (2015–2023)

mycolabadmin

This study examined azole antifungal resistance in fungal infections from a Turkish hospital over nine years. Researchers tested 200 Aspergillus fungal isolates and found that 7% showed resistance to azole medications, with 11% of Aspergillus fumigatus showing resistance. The findings highlight the ongoing challenge of drug-resistant fungal infections and the importance of monitoring resistance patterns to improve treatment decisions for serious fungal infections.

Unveiling the hidden arsenal: exploring secondary metabolites and fungal development in pathogenic fungi

mycolabadmin

Dangerous fungi produce hidden chemical compounds that help them infect humans and crops while also potentially serving as medicines. Scientists are studying how these compounds work and how fungi make them to develop better treatments and protect our food supply. This editorial highlights recent research showing that understanding fungal chemistry from genetic, ecological, and medical perspectives will help us fight fungal diseases as resistance increases.

Detection of Multiple Nosocomial Trichosporon asahii Transmission Events via Microsatellite Typing Assay, South America

mycolabadmin

Researchers developed a genetic fingerprinting tool called microsatellite typing to track and identify outbreaks of a dangerous fungus called Trichosporon asahii in hospitals. This fungus causes life-threatening infections, especially in sick patients with weakened immune systems, and is resistant to many antifungal medications. By analyzing samples from hospitals across South America, scientists discovered multiple instances where the same strain of this fungus infected patients in different hospitals over many years. This new testing method is much cheaper and faster than other genetic tests, making it practical for hospitals worldwide to monitor and control infections caused by this emerging pathogen.

Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018–2023)

mycolabadmin

This research examined dangerous mold infections (Mucormycosis) that became more common after COVID-19. Scientists identified the types of molds causing these infections in Iran by testing 116 patient samples and 65 soil samples from across the country. They tested these molds against 13 different antifungal medications to find which drugs work best. The results showed that amphotericin B and posaconazole were the most effective medications, and patient samples were more susceptible to these drugs than environmental soil samples.

Research Topic: antifungal resistance